Should COVID-19 be branded to viral thrombotic fever?

Should COVID-19 be branded to viral thrombotic fever?

Coronaviruses can cause a diverse array of clinical manifestations, from fever with symptoms of the common cold to highly lethal severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). SARS-CoV-2, the coronavirus discovered in Hubei province, China, at the end of 2019,...

Full description

Bibliographic Details
Main Authors: Rubens Carmo Costa-Filho, Hugo Caire Castro-Faria Neto, José Mengel, Marcelo Pelajo-Machado, Marco Aurélio Martins, Érica Távora Leite, Hugo Tannus Mendonça-Filho, Tatiana de Arruda Campos Brasil de Souza, Gonzalo Bentacor Bello, José Paulo Gagliardi Leite
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2021-04-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
endothelium
COVID-19
SARS-CoV-2
SARS CoV Mpro
inflammation
coagulation
hypercoagulability
thrombosis
thromboelastometry
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762021000100850&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762021000100850&tlng=en

Similar Items